• 1. Excimer emission and magnetoluminescence of radical-based zinc(ii) complexes doped in host crystals?
  Shojiro Kimura,Tetsuro Kusamoto Chem. Commun., 2020,56, 11195-11198
• 2. Evolution and characterization of a benzylguanine-binding RNA aptamer?
  J. Xu,T. J. Carrocci,A. A. Hoskins Chem. Commun., 2016,52, 549-552
• 3. Emulsion soft templating of carbide-derived carbon nanospheres with controllable porosity for capacitive electrochemical energy storage?
  M. Zeiger,N. J?ckel,P. Strubel,L. Borchardt,R. Reinhold,W. Nickel,J. Eckert,V. Presser,S. Kaskel J. Mater. Chem. A, 2015,3, 17983-17990
• 4. Establishing new scaling relations on two-dimensional MXenes for CO2 electroreduction?
  Albertus D. Handoko,Khoong Hong Khoo,Teck Leong Tan,Hongmei Jin,Zhi Wei Seh J. Mater. Chem. A, 2018,6, 21885-21890
• 5. Evolutionary de novo design of phenothiazine derivatives for dye-sensitized solar cells?
  Vishwesh Venkatraman,Marco Foscato,Vidar R. Jensen,Bj?rn K?re Alsberg J. Mater. Chem. A, 2015,3, 9851-9860

Professional Introduction to Compound with CAS No. 485800-29-1 and Product Name: *tert-butyl N-(2-((3-aminopropyl)disulfanyl)ethyl)carbamate*

Compound with the CAS number 485800-29-1 and the product name tert-butyl N-(2-((3-aminopropyl)disulfanyl)ethyl)carbamate represents a significant advancement in the field of chemical biology and pharmaceutical research. This compound, characterized by its unique structural composition, has garnered considerable attention due to its potential applications in drug development and therapeutic interventions.

The molecular structure of this compound features a tert-butyl group attached to a carbamate moiety, which is further linked to an ethyl chain terminated by a disulfanyl group. This configuration imparts distinct chemical properties that make it particularly valuable for synthetic chemistry and medicinal applications. The presence of the (3-aminopropyl)disulfanyl moiety introduces both reactive sites and steric hindrance, which can be exploited in designing molecules with specific biological activities.

In recent years, there has been growing interest in the development of novel compounds that can modulate biological pathways associated with various diseases. The carbamate functional group, in particular, has been extensively studied for its role in drug design due to its ability to form stable bonds with biological targets. This compound’s structure suggests that it may interact with enzymes or receptors in a manner that could lead to therapeutic effects.

One of the most compelling aspects of this compound is its potential application in the development of targeted therapies. The disulfanyl group, known for its ability to cross-link proteins, could be particularly useful in creating molecules that induce protein aggregation or modulate protein-protein interactions. Such mechanisms have been explored in the treatment of neurodegenerative diseases, where protein misfolding and aggregation play a critical role.

The tert-butyl group, on the other hand, provides steric bulk that can influence the compound’s solubility and bioavailability. This feature is crucial in pharmaceutical design, as it can affect how well a drug is absorbed and distributed within the body. By optimizing the size and placement of this group, researchers can fine-tune the pharmacokinetic properties of the compound.

Recent studies have highlighted the importance of disulfanyl-containing compounds in medicinal chemistry. These compounds have shown promise in various therapeutic areas, including anti-inflammatory and anti-cancer applications. The ability of disulfanyl groups to form stable disulfide bonds has been exploited to create molecules that can selectively target diseased cells while minimizing side effects on healthy tissues.

The synthesis of this compound involves multiple steps, each requiring careful optimization to ensure high yield and purity. Advanced synthetic techniques, such as palladium-catalyzed cross-coupling reactions and organometallic chemistry, have been employed to construct the complex molecular framework. These methods not only enhance the efficiency of synthesis but also allow for greater control over the stereochemistry of the final product.

In conclusion, compound with CAS No. 485800-29-1 and product name *tert-butyl N-(2-((3-aminopropyl)disulfanyl)ethyl)carbamate* represents a promising candidate for further research and development in pharmaceuticals. Its unique structural features offer numerous possibilities for designing molecules with tailored biological activities. As research continues to uncover new applications for this class of compounds, it is likely that we will see more innovative therapies emerge based on their chemical properties.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)